Mice lacking Stat1 develop mammary tumors that model human ERα+ breast cancer
DNA sequencing finds a Prlr truncating mutation hotspot in 100% of Stat1−/− tumors
At least 77.8% of DCIS examined also contain PRLR truncating mutations
Co-expression of truncated and full-length PRLR promote tumor growth in MEFs